News

Investing.com -- BioArctic AB shares rose more than 3% on Monday after the U.S. Food and Drug Administration approved a subcutaneous version of Alzheimer’s drug Leqembi for maintenance treatment. The ...
LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat this progressive, relentless disease after initial ...
Abstract: This letter presents a V-band injection-locked frequency divider (ILFD) with high input sensitivity and wide locking range (LR), implemented in 90-nm CMOS technology. The proposed ...
Abstract: This work presents a hybrid biaxial pseudo-random high-frequency signal injection (Bi-PR-HFSI) strategy to suppress high-frequency (HF) torque ripple and electromagnetic (EM) vibration, ...